Heart disease is the number one cause of death worldwide. While individuals can protect their heart by changing their behavior (eat a balanced diet, for example) or their environment (avoid polluted air), they can’t directly alter their risk for developing coronary artery disease (CAD) if that risk is encoded in their DNA.
Philanthropic spouses David S. Vogel and Thais Lopez Vogel believe genomic science can provide humans an edge. So, when they learned about the Prospective Electronic Polygenic Risk Study (PEPRS) at Scripps Research, they were eager to lend their support. Through their VoLo Foundation, they provided $1 million to advance the study’s goal: identify individuals who carry a genetic risk for CAD then calculate that risk as low, intermediate or high—better equipping them to make informed healthcare decisions.